Published in Molecular Cell · View the paper (DOI)
Researchers discover how bacteria evolve mutations that confer antibiotic resistance and find a way to inhibit this process with FDA-approved drug edaravone. The study reveals that low doses of ciprofloxacin induce DNA breaks, leading to mutations in bacterial populations.
Coverage from 2 institutions